ERBB2 and breast cancer: For therapeutic purposes, breast cancers are categorized into three subtypes: estrogen and progesterone receptor (ER, PR)-positive, human epidermal growth factor receptor 2 (HER2)-positive, and triple (ER, PR, and HER2)-negative [2].